nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—Octreotide—MPO—hematologic cancer	0.00114	1	CrCbGaD
Pasireotide—Headache—Hydroxyurea—hematologic cancer	0.000283	0.000461	CcSEcCtD
Pasireotide—Constipation—Gemcitabine—hematologic cancer	0.000283	0.000461	CcSEcCtD
Pasireotide—Abdominal pain—Ifosfamide—hematologic cancer	0.000282	0.00046	CcSEcCtD
Pasireotide—Asthenia—Thiotepa—hematologic cancer	0.000282	0.000459	CcSEcCtD
Pasireotide—Vertigo—Triamcinolone—hematologic cancer	0.000282	0.000459	CcSEcCtD
Pasireotide—Diarrhoea—Vinorelbine—hematologic cancer	0.000281	0.000459	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Cisplatin—hematologic cancer	0.000281	0.000457	CcSEcCtD
Pasireotide—Abdominal distension—Epirubicin—hematologic cancer	0.00028	0.000456	CcSEcCtD
Pasireotide—Nausea—Melphalan—hematologic cancer	0.00028	0.000456	CcSEcCtD
Pasireotide—Dizziness—Bortezomib—hematologic cancer	0.000279	0.000454	CcSEcCtD
Pasireotide—Influenza—Epirubicin—hematologic cancer	0.000278	0.000453	CcSEcCtD
Pasireotide—Pruritus—Thiotepa—hematologic cancer	0.000278	0.000453	CcSEcCtD
Pasireotide—Gastrointestinal pain—Mitoxantrone—hematologic cancer	0.000277	0.000452	CcSEcCtD
Pasireotide—Gastrointestinal pain—Irinotecan—hematologic cancer	0.000277	0.000452	CcSEcCtD
Pasireotide—Abdominal pain—Vincristine—hematologic cancer	0.000275	0.000449	CcSEcCtD
Pasireotide—Dry skin—Doxorubicin—hematologic cancer	0.000273	0.000445	CcSEcCtD
Pasireotide—Asthenia—Thalidomide—hematologic cancer	0.000273	0.000444	CcSEcCtD
Pasireotide—Dizziness—Vinorelbine—hematologic cancer	0.000272	0.000443	CcSEcCtD
Pasireotide—Abdominal pain upper—Doxorubicin—hematologic cancer	0.000272	0.000443	CcSEcCtD
Pasireotide—Nausea—Lenalidomide—hematologic cancer	0.000272	0.000443	CcSEcCtD
Pasireotide—Hypokalaemia—Doxorubicin—hematologic cancer	0.000271	0.000442	CcSEcCtD
Pasireotide—Hypertension—Triamcinolone—hematologic cancer	0.000271	0.000441	CcSEcCtD
Pasireotide—Pruritus—Thalidomide—hematologic cancer	0.000269	0.000438	CcSEcCtD
Pasireotide—Diarrhoea—Thiotepa—hematologic cancer	0.000269	0.000438	CcSEcCtD
Pasireotide—Abdominal pain—Irinotecan—hematologic cancer	0.000268	0.000437	CcSEcCtD
Pasireotide—Abdominal pain—Mitoxantrone—hematologic cancer	0.000268	0.000437	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Doxorubicin—hematologic cancer	0.000268	0.000437	CcSEcCtD
Pasireotide—Nausea—Hydroxyurea—hematologic cancer	0.000268	0.000437	CcSEcCtD
Pasireotide—Vomiting—Bortezomib—hematologic cancer	0.000268	0.000437	CcSEcCtD
Pasireotide—Decreased appetite—Cisplatin—hematologic cancer	0.000268	0.000436	CcSEcCtD
Pasireotide—Myalgia—Triamcinolone—hematologic cancer	0.000267	0.000435	CcSEcCtD
Pasireotide—Nasopharyngitis—Doxorubicin—hematologic cancer	0.000266	0.000434	CcSEcCtD
Pasireotide—Vomiting—Bleomycin—hematologic cancer	0.000266	0.000433	CcSEcCtD
Pasireotide—Headache—Bortezomib—hematologic cancer	0.000264	0.00043	CcSEcCtD
Pasireotide—Hypotension—Etoposide—hematologic cancer	0.000264	0.00043	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Doxorubicin—hematologic cancer	0.000263	0.000428	CcSEcCtD
Pasireotide—Asthenia—Carmustine—hematologic cancer	0.000262	0.000427	CcSEcCtD
Pasireotide—Vomiting—Vinorelbine—hematologic cancer	0.000262	0.000426	CcSEcCtD
Pasireotide—Diarrhoea—Thalidomide—hematologic cancer	0.00026	0.000424	CcSEcCtD
Pasireotide—Dizziness—Thiotepa—hematologic cancer	0.00026	0.000423	CcSEcCtD
Pasireotide—Asthenia—Alitretinoin—hematologic cancer	0.000259	0.000423	CcSEcCtD
Pasireotide—Abdominal distension—Doxorubicin—hematologic cancer	0.000259	0.000422	CcSEcCtD
Pasireotide—Headache—Vinorelbine—hematologic cancer	0.000258	0.00042	CcSEcCtD
Pasireotide—Influenza—Doxorubicin—hematologic cancer	0.000257	0.000419	CcSEcCtD
Pasireotide—Asthenia—Ifosfamide—hematologic cancer	0.000256	0.000418	CcSEcCtD
Pasireotide—Pruritus—Alitretinoin—hematologic cancer	0.000256	0.000417	CcSEcCtD
Pasireotide—Vertigo—Dexamethasone—hematologic cancer	0.000256	0.000417	CcSEcCtD
Pasireotide—Vertigo—Betamethasone—hematologic cancer	0.000256	0.000417	CcSEcCtD
Pasireotide—Pruritus—Ifosfamide—hematologic cancer	0.000253	0.000412	CcSEcCtD
Pasireotide—Insomnia—Prednisolone—hematologic cancer	0.000252	0.00041	CcSEcCtD
Pasireotide—Alopecia—Prednisone—hematologic cancer	0.000252	0.00041	CcSEcCtD
Pasireotide—Dizziness—Thalidomide—hematologic cancer	0.000251	0.00041	CcSEcCtD
Pasireotide—Hyperglycaemia—Epirubicin—hematologic cancer	0.000251	0.000409	CcSEcCtD
Pasireotide—Nausea—Bortezomib—hematologic cancer	0.00025	0.000408	CcSEcCtD
Pasireotide—Asthenia—Vincristine—hematologic cancer	0.00025	0.000407	CcSEcCtD
Pasireotide—Vomiting—Thiotepa—hematologic cancer	0.00025	0.000407	CcSEcCtD
Pasireotide—Diarrhoea—Carmustine—hematologic cancer	0.00025	0.000407	CcSEcCtD
Pasireotide—Nausea—Bleomycin—hematologic cancer	0.000248	0.000405	CcSEcCtD
Pasireotide—Diarrhoea—Alitretinoin—hematologic cancer	0.000247	0.000403	CcSEcCtD
Pasireotide—Headache—Thiotepa—hematologic cancer	0.000246	0.000401	CcSEcCtD
Pasireotide—Hypertension—Dexamethasone—hematologic cancer	0.000246	0.0004	CcSEcCtD
Pasireotide—Hypertension—Betamethasone—hematologic cancer	0.000246	0.0004	CcSEcCtD
Pasireotide—Decreased appetite—Etoposide—hematologic cancer	0.000245	0.0004	CcSEcCtD
Pasireotide—Diarrhoea—Ifosfamide—hematologic cancer	0.000244	0.000398	CcSEcCtD
Pasireotide—Nausea—Vinorelbine—hematologic cancer	0.000244	0.000398	CcSEcCtD
Pasireotide—Asthenia—Mitoxantrone—hematologic cancer	0.000243	0.000397	CcSEcCtD
Pasireotide—Asthenia—Irinotecan—hematologic cancer	0.000243	0.000397	CcSEcCtD
Pasireotide—Fatigue—Etoposide—hematologic cancer	0.000243	0.000397	CcSEcCtD
Pasireotide—Myalgia—Dexamethasone—hematologic cancer	0.000242	0.000395	CcSEcCtD
Pasireotide—Myalgia—Betamethasone—hematologic cancer	0.000242	0.000395	CcSEcCtD
Pasireotide—Vomiting—Thalidomide—hematologic cancer	0.000242	0.000394	CcSEcCtD
Pasireotide—Anxiety—Betamethasone—hematologic cancer	0.000241	0.000393	CcSEcCtD
Pasireotide—Anxiety—Dexamethasone—hematologic cancer	0.000241	0.000393	CcSEcCtD
Pasireotide—Dizziness—Carmustine—hematologic cancer	0.000241	0.000393	CcSEcCtD
Pasireotide—Constipation—Etoposide—hematologic cancer	0.000241	0.000393	CcSEcCtD
Pasireotide—Dizziness—Alitretinoin—hematologic cancer	0.000239	0.00039	CcSEcCtD
Pasireotide—Diarrhoea—Vincristine—hematologic cancer	0.000238	0.000388	CcSEcCtD
Pasireotide—Headache—Thalidomide—hematologic cancer	0.000238	0.000388	CcSEcCtD
Pasireotide—Asthenia—Gemcitabine—hematologic cancer	0.000237	0.000386	CcSEcCtD
Pasireotide—Dizziness—Ifosfamide—hematologic cancer	0.000236	0.000385	CcSEcCtD
Pasireotide—Pruritus—Gemcitabine—hematologic cancer	0.000234	0.000381	CcSEcCtD
Pasireotide—Nausea—Thiotepa—hematologic cancer	0.000233	0.00038	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	0.000233	0.00038	CcSEcCtD
Pasireotide—Hyperglycaemia—Doxorubicin—hematologic cancer	0.000232	0.000378	CcSEcCtD
Pasireotide—Diarrhoea—Mitoxantrone—hematologic cancer	0.000232	0.000378	CcSEcCtD
Pasireotide—Diarrhoea—Irinotecan—hematologic cancer	0.000232	0.000378	CcSEcCtD
Pasireotide—Vomiting—Carmustine—hematologic cancer	0.000232	0.000378	CcSEcCtD
Pasireotide—Insomnia—Triamcinolone—hematologic cancer	0.000232	0.000377	CcSEcCtD
Pasireotide—Gastrointestinal pain—Etoposide—hematologic cancer	0.000231	0.000376	CcSEcCtD
Pasireotide—Dizziness—Vincristine—hematologic cancer	0.00023	0.000375	CcSEcCtD
Pasireotide—Vomiting—Alitretinoin—hematologic cancer	0.00023	0.000375	CcSEcCtD
Pasireotide—Anaemia—Prednisone—hematologic cancer	0.000229	0.000373	CcSEcCtD
Pasireotide—Headache—Carmustine—hematologic cancer	0.000229	0.000373	CcSEcCtD
Pasireotide—Vomiting—Ifosfamide—hematologic cancer	0.000227	0.00037	CcSEcCtD
Pasireotide—Headache—Alitretinoin—hematologic cancer	0.000227	0.000369	CcSEcCtD
Pasireotide—Diarrhoea—Gemcitabine—hematologic cancer	0.000226	0.000369	CcSEcCtD
Pasireotide—Nausea—Thalidomide—hematologic cancer	0.000226	0.000368	CcSEcCtD
Pasireotide—Dizziness—Irinotecan—hematologic cancer	0.000224	0.000366	CcSEcCtD
Pasireotide—Abdominal pain—Etoposide—hematologic cancer	0.000223	0.000364	CcSEcCtD
Pasireotide—Vertigo—Prednisone—hematologic cancer	0.000223	0.000363	CcSEcCtD
Pasireotide—Vomiting—Vincristine—hematologic cancer	0.000222	0.000361	CcSEcCtD
Pasireotide—Asthenia—Cisplatin—hematologic cancer	0.000221	0.00036	CcSEcCtD
Pasireotide—Fatigue—Triamcinolone—hematologic cancer	0.000221	0.00036	CcSEcCtD
Pasireotide—Oedema peripheral—Epirubicin—hematologic cancer	0.000219	0.000357	CcSEcCtD
Pasireotide—Headache—Vincristine—hematologic cancer	0.000218	0.000356	CcSEcCtD
Pasireotide—Hypotension—Betamethasone—hematologic cancer	0.000217	0.000354	CcSEcCtD
Pasireotide—Hypotension—Dexamethasone—hematologic cancer	0.000217	0.000354	CcSEcCtD
Pasireotide—Nausea—Carmustine—hematologic cancer	0.000217	0.000353	CcSEcCtD
Pasireotide—Vomiting—Irinotecan—hematologic cancer	0.000216	0.000352	CcSEcCtD
Pasireotide—Vomiting—Mitoxantrone—hematologic cancer	0.000216	0.000352	CcSEcCtD
Pasireotide—Nausea—Alitretinoin—hematologic cancer	0.000215	0.00035	CcSEcCtD
Pasireotide—Hypertension—Prednisone—hematologic cancer	0.000214	0.000349	CcSEcCtD
Pasireotide—Headache—Irinotecan—hematologic cancer	0.000213	0.000346	CcSEcCtD
Pasireotide—Headache—Mitoxantrone—hematologic cancer	0.000213	0.000346	CcSEcCtD
Pasireotide—Nausea—Ifosfamide—hematologic cancer	0.000212	0.000346	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	0.000212	0.000345	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Betamethasone—hematologic cancer	0.000212	0.000345	CcSEcCtD
Pasireotide—Myalgia—Prednisone—hematologic cancer	0.000211	0.000344	CcSEcCtD
Pasireotide—Arthralgia—Prednisone—hematologic cancer	0.000211	0.000344	CcSEcCtD
Pasireotide—Diarrhoea—Cisplatin—hematologic cancer	0.000211	0.000343	CcSEcCtD
Pasireotide—Anxiety—Prednisone—hematologic cancer	0.00021	0.000343	CcSEcCtD
Pasireotide—Alopecia—Methotrexate—hematologic cancer	0.00021	0.000343	CcSEcCtD
Pasireotide—Vomiting—Gemcitabine—hematologic cancer	0.00021	0.000342	CcSEcCtD
Pasireotide—Insomnia—Betamethasone—hematologic cancer	0.00021	0.000342	CcSEcCtD
Pasireotide—Insomnia—Dexamethasone—hematologic cancer	0.00021	0.000342	CcSEcCtD
Pasireotide—Headache—Gemcitabine—hematologic cancer	0.000207	0.000337	CcSEcCtD
Pasireotide—Nausea—Vincristine—hematologic cancer	0.000207	0.000337	CcSEcCtD
Pasireotide—Oedema peripheral—Doxorubicin—hematologic cancer	0.000203	0.000331	CcSEcCtD
Pasireotide—Asthenia—Etoposide—hematologic cancer	0.000202	0.00033	CcSEcCtD
Pasireotide—Decreased appetite—Betamethasone—hematologic cancer	0.000202	0.000329	CcSEcCtD
Pasireotide—Decreased appetite—Dexamethasone—hematologic cancer	0.000202	0.000329	CcSEcCtD
Pasireotide—Nausea—Mitoxantrone—hematologic cancer	0.000202	0.000328	CcSEcCtD
Pasireotide—Nausea—Irinotecan—hematologic cancer	0.000202	0.000328	CcSEcCtD
Pasireotide—Back pain—Methotrexate—hematologic cancer	0.0002	0.000327	CcSEcCtD
Pasireotide—Fatigue—Betamethasone—hematologic cancer	0.0002	0.000326	CcSEcCtD
Pasireotide—Fatigue—Dexamethasone—hematologic cancer	0.0002	0.000326	CcSEcCtD
Pasireotide—Pruritus—Etoposide—hematologic cancer	0.0002	0.000325	CcSEcCtD
Pasireotide—Alopecia—Epirubicin—hematologic cancer	0.000197	0.000321	CcSEcCtD
Pasireotide—Nausea—Gemcitabine—hematologic cancer	0.000196	0.00032	CcSEcCtD
Pasireotide—Vomiting—Cisplatin—hematologic cancer	0.000196	0.000319	CcSEcCtD
Pasireotide—Diarrhoea—Etoposide—hematologic cancer	0.000193	0.000315	CcSEcCtD
Pasireotide—Anaemia—Methotrexate—hematologic cancer	0.000191	0.000312	CcSEcCtD
Pasireotide—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.00019	0.00031	CcSEcCtD
Pasireotide—Gastrointestinal pain—Betamethasone—hematologic cancer	0.00019	0.00031	CcSEcCtD
Pasireotide—Back pain—Epirubicin—hematologic cancer	0.000188	0.000306	CcSEcCtD
Pasireotide—Dizziness—Etoposide—hematologic cancer	0.000187	0.000304	CcSEcCtD
Pasireotide—Vertigo—Methotrexate—hematologic cancer	0.000186	0.000303	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Prednisone—hematologic cancer	0.000184	0.0003	CcSEcCtD
Pasireotide—Dizziness—Prednisolone—hematologic cancer	0.000184	0.0003	CcSEcCtD
Pasireotide—Asthenia—Triamcinolone—hematologic cancer	0.000184	0.000299	CcSEcCtD
Pasireotide—Abdominal pain—Betamethasone—hematologic cancer	0.000184	0.000299	CcSEcCtD
Pasireotide—Abdominal pain—Dexamethasone—hematologic cancer	0.000184	0.000299	CcSEcCtD
Pasireotide—Nausea—Cisplatin—hematologic cancer	0.000183	0.000298	CcSEcCtD
Pasireotide—Insomnia—Prednisone—hematologic cancer	0.000183	0.000298	CcSEcCtD
Pasireotide—Alopecia—Doxorubicin—hematologic cancer	0.000182	0.000297	CcSEcCtD
Pasireotide—Pruritus—Triamcinolone—hematologic cancer	0.000181	0.000295	CcSEcCtD
Pasireotide—Vomiting—Etoposide—hematologic cancer	0.000179	0.000292	CcSEcCtD
Pasireotide—Anaemia—Epirubicin—hematologic cancer	0.000179	0.000292	CcSEcCtD
Pasireotide—Headache—Etoposide—hematologic cancer	0.000177	0.000288	CcSEcCtD
Pasireotide—Myalgia—Methotrexate—hematologic cancer	0.000176	0.000287	CcSEcCtD
Pasireotide—Arthralgia—Methotrexate—hematologic cancer	0.000176	0.000287	CcSEcCtD
Pasireotide—Decreased appetite—Prednisone—hematologic cancer	0.000176	0.000287	CcSEcCtD
Pasireotide—Fatigue—Prednisone—hematologic cancer	0.000174	0.000284	CcSEcCtD
Pasireotide—Headache—Prednisolone—hematologic cancer	0.000174	0.000284	CcSEcCtD
Pasireotide—Vertigo—Epirubicin—hematologic cancer	0.000174	0.000284	CcSEcCtD
Pasireotide—Back pain—Doxorubicin—hematologic cancer	0.000173	0.000283	CcSEcCtD
Pasireotide—Constipation—Prednisone—hematologic cancer	0.000173	0.000282	CcSEcCtD
Pasireotide—Dizziness—Triamcinolone—hematologic cancer	0.000169	0.000276	CcSEcCtD
Pasireotide—Nausea—Etoposide—hematologic cancer	0.000168	0.000273	CcSEcCtD
Pasireotide—Hypertension—Epirubicin—hematologic cancer	0.000167	0.000273	CcSEcCtD
Pasireotide—Asthenia—Dexamethasone—hematologic cancer	0.000167	0.000272	CcSEcCtD
Pasireotide—Asthenia—Betamethasone—hematologic cancer	0.000167	0.000272	CcSEcCtD
Pasireotide—Anaemia—Doxorubicin—hematologic cancer	0.000166	0.00027	CcSEcCtD
Pasireotide—Gastrointestinal pain—Prednisone—hematologic cancer	0.000165	0.00027	CcSEcCtD
Pasireotide—Nausea—Prednisolone—hematologic cancer	0.000165	0.000269	CcSEcCtD
Pasireotide—Arthralgia—Epirubicin—hematologic cancer	0.000165	0.000269	CcSEcCtD
Pasireotide—Myalgia—Epirubicin—hematologic cancer	0.000165	0.000269	CcSEcCtD
Pasireotide—Anxiety—Epirubicin—hematologic cancer	0.000164	0.000268	CcSEcCtD
Pasireotide—Pruritus—Dexamethasone—hematologic cancer	0.000164	0.000268	CcSEcCtD
Pasireotide—Pruritus—Betamethasone—hematologic cancer	0.000164	0.000268	CcSEcCtD
Pasireotide—Vomiting—Triamcinolone—hematologic cancer	0.000163	0.000265	CcSEcCtD
Pasireotide—Vertigo—Doxorubicin—hematologic cancer	0.000161	0.000263	CcSEcCtD
Pasireotide—Headache—Triamcinolone—hematologic cancer	0.00016	0.000261	CcSEcCtD
Pasireotide—Abdominal pain—Prednisone—hematologic cancer	0.00016	0.000261	CcSEcCtD
Pasireotide—Diarrhoea—Betamethasone—hematologic cancer	0.000159	0.000259	CcSEcCtD
Pasireotide—Diarrhoea—Dexamethasone—hematologic cancer	0.000159	0.000259	CcSEcCtD
Pasireotide—Hypotension—Methotrexate—hematologic cancer	0.000158	0.000257	CcSEcCtD
Pasireotide—Hypertension—Doxorubicin—hematologic cancer	0.000155	0.000252	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Methotrexate—hematologic cancer	0.000154	0.000251	CcSEcCtD
Pasireotide—Dizziness—Dexamethasone—hematologic cancer	0.000154	0.00025	CcSEcCtD
Pasireotide—Dizziness—Betamethasone—hematologic cancer	0.000154	0.00025	CcSEcCtD
Pasireotide—Insomnia—Methotrexate—hematologic cancer	0.000153	0.000249	CcSEcCtD
Pasireotide—Arthralgia—Doxorubicin—hematologic cancer	0.000153	0.000249	CcSEcCtD
Pasireotide—Myalgia—Doxorubicin—hematologic cancer	0.000153	0.000249	CcSEcCtD
Pasireotide—Anxiety—Doxorubicin—hematologic cancer	0.000152	0.000248	CcSEcCtD
Pasireotide—Nausea—Triamcinolone—hematologic cancer	0.000152	0.000248	CcSEcCtD
Pasireotide—Hypotension—Epirubicin—hematologic cancer	0.000148	0.000241	CcSEcCtD
Pasireotide—Vomiting—Betamethasone—hematologic cancer	0.000148	0.000241	CcSEcCtD
Pasireotide—Vomiting—Dexamethasone—hematologic cancer	0.000148	0.000241	CcSEcCtD
Pasireotide—Decreased appetite—Methotrexate—hematologic cancer	0.000147	0.000239	CcSEcCtD
Pasireotide—Fatigue—Methotrexate—hematologic cancer	0.000146	0.000238	CcSEcCtD
Pasireotide—Headache—Betamethasone—hematologic cancer	0.000146	0.000237	CcSEcCtD
Pasireotide—Headache—Dexamethasone—hematologic cancer	0.000146	0.000237	CcSEcCtD
Pasireotide—Asthenia—Prednisone—hematologic cancer	0.000145	0.000237	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Epirubicin—hematologic cancer	0.000144	0.000235	CcSEcCtD
Pasireotide—Pruritus—Prednisone—hematologic cancer	0.000143	0.000233	CcSEcCtD
Pasireotide—Insomnia—Epirubicin—hematologic cancer	0.000143	0.000233	CcSEcCtD
Pasireotide—Diarrhoea—Prednisone—hematologic cancer	0.000138	0.000226	CcSEcCtD
Pasireotide—Gastrointestinal pain—Methotrexate—hematologic cancer	0.000138	0.000225	CcSEcCtD
Pasireotide—Nausea—Dexamethasone—hematologic cancer	0.000138	0.000225	CcSEcCtD
Pasireotide—Nausea—Betamethasone—hematologic cancer	0.000138	0.000225	CcSEcCtD
Pasireotide—Decreased appetite—Epirubicin—hematologic cancer	0.000138	0.000224	CcSEcCtD
Pasireotide—Hypotension—Doxorubicin—hematologic cancer	0.000137	0.000223	CcSEcCtD
Pasireotide—Fatigue—Epirubicin—hematologic cancer	0.000136	0.000222	CcSEcCtD
Pasireotide—Constipation—Epirubicin—hematologic cancer	0.000135	0.00022	CcSEcCtD
Pasireotide—Dizziness—Prednisone—hematologic cancer	0.000134	0.000218	CcSEcCtD
Pasireotide—Abdominal pain—Methotrexate—hematologic cancer	0.000134	0.000218	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	0.000133	0.000217	CcSEcCtD
Pasireotide—Insomnia—Doxorubicin—hematologic cancer	0.000132	0.000216	CcSEcCtD
Pasireotide—Gastrointestinal pain—Epirubicin—hematologic cancer	0.000129	0.000211	CcSEcCtD
Pasireotide—Vomiting—Prednisone—hematologic cancer	0.000129	0.00021	CcSEcCtD
Pasireotide—Decreased appetite—Doxorubicin—hematologic cancer	0.000127	0.000207	CcSEcCtD
Pasireotide—Headache—Prednisone—hematologic cancer	0.000127	0.000207	CcSEcCtD
Pasireotide—Fatigue—Doxorubicin—hematologic cancer	0.000126	0.000206	CcSEcCtD
Pasireotide—Constipation—Doxorubicin—hematologic cancer	0.000125	0.000204	CcSEcCtD
Pasireotide—Abdominal pain—Epirubicin—hematologic cancer	0.000125	0.000204	CcSEcCtD
Pasireotide—Asthenia—Methotrexate—hematologic cancer	0.000121	0.000198	CcSEcCtD
Pasireotide—Nausea—Prednisone—hematologic cancer	0.00012	0.000196	CcSEcCtD
Pasireotide—Gastrointestinal pain—Doxorubicin—hematologic cancer	0.00012	0.000195	CcSEcCtD
Pasireotide—Pruritus—Methotrexate—hematologic cancer	0.00012	0.000195	CcSEcCtD
Pasireotide—Abdominal pain—Doxorubicin—hematologic cancer	0.000116	0.000189	CcSEcCtD
Pasireotide—Diarrhoea—Methotrexate—hematologic cancer	0.000116	0.000188	CcSEcCtD
Pasireotide—Asthenia—Epirubicin—hematologic cancer	0.000114	0.000185	CcSEcCtD
Pasireotide—Pruritus—Epirubicin—hematologic cancer	0.000112	0.000182	CcSEcCtD
Pasireotide—Dizziness—Methotrexate—hematologic cancer	0.000112	0.000182	CcSEcCtD
Pasireotide—Diarrhoea—Epirubicin—hematologic cancer	0.000108	0.000176	CcSEcCtD
Pasireotide—Vomiting—Methotrexate—hematologic cancer	0.000107	0.000175	CcSEcCtD
Pasireotide—Headache—Methotrexate—hematologic cancer	0.000106	0.000173	CcSEcCtD
Pasireotide—Asthenia—Doxorubicin—hematologic cancer	0.000105	0.000171	CcSEcCtD
Pasireotide—Dizziness—Epirubicin—hematologic cancer	0.000105	0.00017	CcSEcCtD
Pasireotide—Pruritus—Doxorubicin—hematologic cancer	0.000104	0.000169	CcSEcCtD
Pasireotide—Vomiting—Epirubicin—hematologic cancer	0.000101	0.000164	CcSEcCtD
Pasireotide—Nausea—Methotrexate—hematologic cancer	0.0001	0.000164	CcSEcCtD
Pasireotide—Diarrhoea—Doxorubicin—hematologic cancer	0.0001	0.000163	CcSEcCtD
Pasireotide—Headache—Epirubicin—hematologic cancer	9.91e-05	0.000162	CcSEcCtD
Pasireotide—Dizziness—Doxorubicin—hematologic cancer	9.68e-05	0.000158	CcSEcCtD
Pasireotide—Nausea—Epirubicin—hematologic cancer	9.4e-05	0.000153	CcSEcCtD
Pasireotide—Vomiting—Doxorubicin—hematologic cancer	9.31e-05	0.000152	CcSEcCtD
Pasireotide—Headache—Doxorubicin—hematologic cancer	9.17e-05	0.000149	CcSEcCtD
Pasireotide—Nausea—Doxorubicin—hematologic cancer	8.69e-05	0.000142	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—PDGFB—hematologic cancer	8.64e-05	0.000224	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CB—hematologic cancer	8.58e-05	0.000223	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3R1—hematologic cancer	8.57e-05	0.000223	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PDGFRA—hematologic cancer	8.53e-05	0.000221	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—JAK1—hematologic cancer	8.5e-05	0.000221	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PRKCG—hematologic cancer	8.5e-05	0.000221	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—FGFR3—hematologic cancer	8.47e-05	0.00022	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TSC2—hematologic cancer	8.44e-05	0.000219	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MAPK14—hematologic cancer	8.38e-05	0.000218	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CD86—hematologic cancer	8.38e-05	0.000218	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—JAK2—hematologic cancer	8.33e-05	0.000216	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HES1—hematologic cancer	8.26e-05	0.000215	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ESR1—hematologic cancer	8.23e-05	0.000214	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NCOR1—hematologic cancer	8.22e-05	0.000213	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—FN1—hematologic cancer	8.12e-05	0.000211	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FGF1—hematologic cancer	8.12e-05	0.000211	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CSF2—hematologic cancer	8.12e-05	0.000211	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—FGFR3—hematologic cancer	8.12e-05	0.000211	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MAPK14—hematologic cancer	8.04e-05	0.000209	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—BAD—hematologic cancer	8.03e-05	0.000208	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NFKBIA—hematologic cancer	8.03e-05	0.000208	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FOXO1—hematologic cancer	8.01e-05	0.000208	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—IL2—hematologic cancer	8e-05	0.000208	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PDGFRB—hematologic cancer	7.99e-05	0.000207	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NOTCH1—hematologic cancer	7.95e-05	0.000206	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL2RA—hematologic cancer	7.94e-05	0.000206	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CB—hematologic cancer	7.91e-05	0.000205	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ESR1—hematologic cancer	7.89e-05	0.000205	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL2—hematologic cancer	7.88e-05	0.000204	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PDGFRA—hematologic cancer	7.87e-05	0.000204	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TERT—hematologic cancer	7.85e-05	0.000204	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PRKCG—hematologic cancer	7.84e-05	0.000204	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—JAK1—hematologic cancer	7.84e-05	0.000204	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—FN1—hematologic cancer	7.79e-05	0.000202	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CD80—hematologic cancer	7.79e-05	0.000202	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CG—hematologic cancer	7.78e-05	0.000202	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KIT—hematologic cancer	7.78e-05	0.000202	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—NRAS—hematologic cancer	7.78e-05	0.000202	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NFKBIA—hematologic cancer	7.7e-05	0.0002	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—BAD—hematologic cancer	7.7e-05	0.0002	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PDGFB—hematologic cancer	7.66e-05	0.000199	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PTPN11—hematologic cancer	7.64e-05	0.000198	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NOTCH1—hematologic cancer	7.62e-05	0.000198	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TSC2—hematologic cancer	7.49e-05	0.000194	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CD80—hematologic cancer	7.47e-05	0.000194	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CG—hematologic cancer	7.45e-05	0.000194	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KIT—hematologic cancer	7.45e-05	0.000194	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—NRAS—hematologic cancer	7.45e-05	0.000194	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—MAPK3—hematologic cancer	7.45e-05	0.000193	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CREB1—hematologic cancer	7.4e-05	0.000192	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PTPN11—hematologic cancer	7.32e-05	0.00019	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL2RA—hematologic cancer	7.32e-05	0.00019	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—BRAF—hematologic cancer	7.31e-05	0.00019	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL2—hematologic cancer	7.27e-05	0.000189	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCL2—hematologic cancer	7.24e-05	0.000188	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TERT—hematologic cancer	7.24e-05	0.000188	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL6R—hematologic cancer	7.22e-05	0.000187	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CREBBP—hematologic cancer	7.21e-05	0.000187	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FGFR3—hematologic cancer	7.2e-05	0.000187	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—MAPK3—hematologic cancer	7.14e-05	0.000185	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MAPK14—hematologic cancer	7.13e-05	0.000185	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CREB1—hematologic cancer	7.1e-05	0.000184	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PDGFB—hematologic cancer	7.07e-05	0.000183	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—BRAF—hematologic cancer	7.01e-05	0.000182	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ESR1—hematologic cancer	6.99e-05	0.000182	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCL2—hematologic cancer	6.94e-05	0.00018	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL6R—hematologic cancer	6.92e-05	0.00018	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CREBBP—hematologic cancer	6.91e-05	0.000179	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TSC2—hematologic cancer	6.91e-05	0.000179	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FN1—hematologic cancer	6.91e-05	0.000179	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MAP2K1—hematologic cancer	6.88e-05	0.000179	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CD—hematologic cancer	6.84e-05	0.000177	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—BAD—hematologic cancer	6.83e-05	0.000177	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NFKBIA—hematologic cancer	6.83e-05	0.000177	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—PIK3CA—hematologic cancer	6.77e-05	0.000176	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NOTCH1—hematologic cancer	6.76e-05	0.000175	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—KRAS—hematologic cancer	6.69e-05	0.000174	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FGFR3—hematologic cancer	6.65e-05	0.000173	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CD80—hematologic cancer	6.62e-05	0.000172	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CG—hematologic cancer	6.61e-05	0.000172	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KIT—hematologic cancer	6.61e-05	0.000172	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—NRAS—hematologic cancer	6.61e-05	0.000172	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MAP2K1—hematologic cancer	6.6e-05	0.000171	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MAPK14—hematologic cancer	6.58e-05	0.000171	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CD—hematologic cancer	6.55e-05	0.00017	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—FGF2—hematologic cancer	6.54e-05	0.00017	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PTPN11—hematologic cancer	6.5e-05	0.000169	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—PIK3CA—hematologic cancer	6.49e-05	0.000168	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ESR1—hematologic cancer	6.45e-05	0.000168	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3R1—hematologic cancer	6.45e-05	0.000168	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—KRAS—hematologic cancer	6.42e-05	0.000167	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FN1—hematologic cancer	6.38e-05	0.000166	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—MAPK3—hematologic cancer	6.33e-05	0.000164	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—BAD—hematologic cancer	6.3e-05	0.000164	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NFKBIA—hematologic cancer	6.3e-05	0.000164	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CREB1—hematologic cancer	6.29e-05	0.000163	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—FGF2—hematologic cancer	6.27e-05	0.000163	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—JAK2—hematologic cancer	6.27e-05	0.000163	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NOTCH1—hematologic cancer	6.24e-05	0.000162	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—BRAF—hematologic cancer	6.21e-05	0.000161	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3R1—hematologic cancer	6.19e-05	0.000161	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCL2—hematologic cancer	6.16e-05	0.00016	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PIK3CA—hematologic cancer	6.15e-05	0.00016	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL6R—hematologic cancer	6.14e-05	0.000159	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CREBBP—hematologic cancer	6.13e-05	0.000159	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MDM2—hematologic cancer	6.12e-05	0.000159	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CD80—hematologic cancer	6.11e-05	0.000159	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CG—hematologic cancer	6.1e-05	0.000158	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KIT—hematologic cancer	6.1e-05	0.000158	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—NRAS—hematologic cancer	6.1e-05	0.000158	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—JAK2—hematologic cancer	6.01e-05	0.000156	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PTPN11—hematologic cancer	5.99e-05	0.000156	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MTOR—hematologic cancer	5.96e-05	0.000155	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CB—hematologic cancer	5.96e-05	0.000155	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PIK3CA—hematologic cancer	5.89e-05	0.000153	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MDM2—hematologic cancer	5.87e-05	0.000152	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MAP2K1—hematologic cancer	5.85e-05	0.000152	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—MAPK3—hematologic cancer	5.84e-05	0.000152	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CD—hematologic cancer	5.81e-05	0.000151	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CREB1—hematologic cancer	5.81e-05	0.000151	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PIK3CA—hematologic cancer	5.76e-05	0.000149	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—BRAF—hematologic cancer	5.73e-05	0.000149	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MTOR—hematologic cancer	5.71e-05	0.000148	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CB—hematologic cancer	5.71e-05	0.000148	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—KRAS—hematologic cancer	5.69e-05	0.000148	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—HRAS—hematologic cancer	5.69e-05	0.000148	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCL2—hematologic cancer	5.68e-05	0.000148	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL6R—hematologic cancer	5.67e-05	0.000147	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CREBBP—hematologic cancer	5.66e-05	0.000147	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CDKN1B—hematologic cancer	5.59e-05	0.000145	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FGF2—hematologic cancer	5.56e-05	0.000144	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—AKT1—hematologic cancer	5.53e-05	0.000144	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3R1—hematologic cancer	5.49e-05	0.000142	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CASP3—hematologic cancer	5.48e-05	0.000142	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL2—hematologic cancer	5.47e-05	0.000142	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—HRAS—hematologic cancer	5.45e-05	0.000142	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL6—hematologic cancer	5.44e-05	0.000141	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MAP2K1—hematologic cancer	5.4e-05	0.00014	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CD—hematologic cancer	5.36e-05	0.000139	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CDKN1B—hematologic cancer	5.36e-05	0.000139	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCND1—hematologic cancer	5.33e-05	0.000138	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—JAK2—hematologic cancer	5.33e-05	0.000138	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—JUN—hematologic cancer	5.32e-05	0.000138	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3CA—hematologic cancer	5.31e-05	0.000138	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—AKT1—hematologic cancer	5.3e-05	0.000138	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CASP3—hematologic cancer	5.25e-05	0.000136	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—KRAS—hematologic cancer	5.25e-05	0.000136	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL2—hematologic cancer	5.25e-05	0.000136	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CA—hematologic cancer	5.23e-05	0.000136	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL6—hematologic cancer	5.22e-05	0.000135	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MDM2—hematologic cancer	5.21e-05	0.000135	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CDKN1A—hematologic cancer	5.16e-05	0.000134	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PTEN—hematologic cancer	5.15e-05	0.000134	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FGF2—hematologic cancer	5.14e-05	0.000133	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCND1—hematologic cancer	5.11e-05	0.000133	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—JUN—hematologic cancer	5.1e-05	0.000132	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CB—hematologic cancer	5.07e-05	0.000132	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MTOR—hematologic cancer	5.07e-05	0.000132	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3R1—hematologic cancer	5.06e-05	0.000131	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MAPK8—hematologic cancer	5.04e-05	0.000131	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—AKT1—hematologic cancer	5.02e-05	0.00013	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CDKN1A—hematologic cancer	4.95e-05	0.000128	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PTEN—hematologic cancer	4.94e-05	0.000128	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—JAK2—hematologic cancer	4.92e-05	0.000128	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—EP300—hematologic cancer	4.91e-05	0.000127	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—HRAS—hematologic cancer	4.84e-05	0.000126	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MAPK8—hematologic cancer	4.83e-05	0.000125	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CA—hematologic cancer	4.82e-05	0.000125	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—AKT1—hematologic cancer	4.82e-05	0.000125	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MDM2—hematologic cancer	4.81e-05	0.000125	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SRC—hematologic cancer	4.77e-05	0.000124	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CDKN1B—hematologic cancer	4.75e-05	0.000123	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—EP300—hematologic cancer	4.71e-05	0.000122	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—AKT1—hematologic cancer	4.7e-05	0.000122	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CB—hematologic cancer	4.68e-05	0.000121	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MTOR—hematologic cancer	4.68e-05	0.000121	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CASP3—hematologic cancer	4.66e-05	0.000121	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL2—hematologic cancer	4.65e-05	0.000121	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—VEGFA—hematologic cancer	4.65e-05	0.000121	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL6—hematologic cancer	4.63e-05	0.00012	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—STAT3—hematologic cancer	4.6e-05	0.00012	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NRAS—hematologic cancer	4.59e-05	0.000119	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SRC—hematologic cancer	4.58e-05	0.000119	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCND1—hematologic cancer	4.54e-05	0.000118	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—JUN—hematologic cancer	4.53e-05	0.000117	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—HRAS—hematologic cancer	4.46e-05	0.000116	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—VEGFA—hematologic cancer	4.46e-05	0.000116	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—STAT3—hematologic cancer	4.41e-05	0.000115	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NRAS—hematologic cancer	4.4e-05	0.000114	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MAPK3—hematologic cancer	4.4e-05	0.000114	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CDKN1A—hematologic cancer	4.39e-05	0.000114	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CDKN1B—hematologic cancer	4.39e-05	0.000114	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PTEN—hematologic cancer	4.38e-05	0.000114	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—AKT1—hematologic cancer	4.34e-05	0.000113	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CASP3—hematologic cancer	4.3e-05	0.000112	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL2—hematologic cancer	4.29e-05	0.000111	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MAPK8—hematologic cancer	4.28e-05	0.000111	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MYC—hematologic cancer	4.28e-05	0.000111	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL6—hematologic cancer	4.27e-05	0.000111	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—AKT1—hematologic cancer	4.27e-05	0.000111	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TGFB1—hematologic cancer	4.27e-05	0.000111	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MAPK3—hematologic cancer	4.22e-05	0.000109	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCND1—hematologic cancer	4.19e-05	0.000109	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—JUN—hematologic cancer	4.18e-05	0.000108	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—EP300—hematologic cancer	4.17e-05	0.000108	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MYC—hematologic cancer	4.1e-05	0.000106	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TGFB1—hematologic cancer	4.09e-05	0.000106	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SRC—hematologic cancer	4.06e-05	0.000105	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CDKN1A—hematologic cancer	4.05e-05	0.000105	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PTEN—hematologic cancer	4.04e-05	0.000105	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—VEGFA—hematologic cancer	3.95e-05	0.000103	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KRAS—hematologic cancer	3.95e-05	0.000103	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MAPK8—hematologic cancer	3.95e-05	0.000103	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—AKT1—hematologic cancer	3.94e-05	0.000102	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—STAT3—hematologic cancer	3.91e-05	0.000102	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NRAS—hematologic cancer	3.91e-05	0.000101	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—EP300—hematologic cancer	3.85e-05	0.0001	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KRAS—hematologic cancer	3.79e-05	9.84e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SRC—hematologic cancer	3.75e-05	9.73e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MAPK3—hematologic cancer	3.74e-05	9.71e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—VEGFA—hematologic cancer	3.65e-05	9.47e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MYC—hematologic cancer	3.64e-05	9.44e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CA—hematologic cancer	3.63e-05	9.43e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TGFB1—hematologic cancer	3.63e-05	9.42e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—STAT3—hematologic cancer	3.61e-05	9.38e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NRAS—hematologic cancer	3.6e-05	9.36e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TP53—hematologic cancer	3.51e-05	9.12e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CA—hematologic cancer	3.48e-05	9.04e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MAPK3—hematologic cancer	3.45e-05	8.96e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TP53—hematologic cancer	3.37e-05	8.74e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KRAS—hematologic cancer	3.36e-05	8.73e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HRAS—hematologic cancer	3.36e-05	8.72e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MYC—hematologic cancer	3.36e-05	8.72e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TGFB1—hematologic cancer	3.35e-05	8.69e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HRAS—hematologic cancer	3.22e-05	8.36e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL6—hematologic cancer	3.22e-05	8.35e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KRAS—hematologic cancer	3.1e-05	8.05e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CA—hematologic cancer	3.09e-05	8.02e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL6—hematologic cancer	3.08e-05	8e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TP53—hematologic cancer	2.99e-05	7.76e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—AKT1—hematologic cancer	2.97e-05	7.7e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HRAS—hematologic cancer	2.86e-05	7.42e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CA—hematologic cancer	2.85e-05	7.4e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AKT1—hematologic cancer	2.84e-05	7.38e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TP53—hematologic cancer	2.76e-05	7.16e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL6—hematologic cancer	2.73e-05	7.1e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HRAS—hematologic cancer	2.64e-05	6.84e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL6—hematologic cancer	2.52e-05	6.55e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AKT1—hematologic cancer	2.52e-05	6.55e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AKT1—hematologic cancer	2.33e-05	6.04e-05	CbGpPWpGaD
